A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/13 (2006.01) A61P 25/28 (2006.01)
Patent
CA 2143752
Disclosed is a method for reducing non-ischemic NMDA receptor-mediated neuronal damage in a mammal by administering to the mammal a compound of the formula shown in Fig. 1 (or a physiologically- acceptable salt thereof), wherein R1 includes an amino group, R2-R17 are independently H or a short chain aliphatic group comprising 1-5 carbons, and R4 and R10 also may (independently) be a halogen or an acyl group. Also disclosed is a screen for antagonists of NMDA receptor mediated neurotoxicity which have an enhanced prospect for being clinically tolerated and selective against such neurotoxicity.
Smart & Biggar
The Children's Medical Center Corporation
LandOfFree
Method of preventing nmda receptor-mediated neuronal damage does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of preventing nmda receptor-mediated neuronal damage, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of preventing nmda receptor-mediated neuronal damage will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1665282